Neumora Therapeutics (NMRA) Prepaid Assets (2022 - 2026)
Neumora Therapeutics (NMRA) posted quarterly Prepaid Assets of $6.4 million for Q1 2026, up 47.95% year-over-year from $4.3 million in Q1 2025, and down 20.54% quarter-over-quarter from $8.0 million in Q4 2025.
Neumora Therapeutics (NMRA) Prepaid Assets (2022 - 2026) Analysis & Trends
Neumora Therapeutics' Prepaid Assets history runs 5 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 47.95% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (up 47.95% YoY), while the FY2025 annual figure was $8.0 million, up 52.11% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6.4 million, down from $8.0 million in the prior quarter.
- The five-year high for Prepaid Assets was $24.3 million in Q4 2023, with the low at $1.6 million in Q3 2023.
- The 5-year median for Prepaid Assets is $5.4 million (2025), against an average of $7.3 million.
- Peak annual rise in Prepaid Assets reached 292.27% in 2024, while the deepest fall reached 78.33% in 2024.
- Neumora Therapeutics' Prepaid Assets stood at $11.9 million in 2022, then jumped by 104.18% to $24.3 million in 2023, then slumped by 78.33% to $5.3 million in 2024, then soared by 52.11% to $8.0 million in 2025, then retreated by 20.54% to $6.4 million in 2026.
- Business Quant data shows NMRA's Prepaid Assets at $6.4 million in Q1 2026, $8.0 million in Q4 2025, and $5.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Neumora Therapeutics | 296.45 Mn | 296.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 8.01 Mn |
| Sep 30, 2025 | 5.56 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Dec 31, 2024 | 5.26 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Mar 31, 2024 | 4.56 Mn |
| Dec 31, 2023 | 24.30 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Dec 31, 2022 | 11.90 Mn |